Screener Summaries Updates Institutions Sign In More Updates › Other Events › EW Other Events · May 8, 2026
Edwards Lifesciences Corporation stockholders approved an amendment to the company's Long-Term Stock Incentive… EW Edwards Lifesciences Corp
Edwards Lifesciences Corporation stockholders approved an amendment to the company's Long-Term Stock Incentive Compensation Program, increasing the total share pool by 7,000,000 shares to a new limit of 341,500,000 shares. The company also confirmed the election of its board of directors and the ratification of PricewaterhouseCoopers LLP as its independent auditor during the 2026 Annual Meeting.
More from Edwards Lifesciences Corp Edwards Lifesciences raises full-year sales growth guidance to approx 11.5% after Q3 revenue of $1.72B Nov 4, 2026 Edwards Lifesciences Corporation announced that Donald E. Bobo, Jr., Corporate Vice President of Strategy and… Aug 28, 2026 Edwards Lifesciences reported second quarter 2026 sales of $1.74 billion, a 13.6% increase year-over-year, with… Jul 23, 2026 Edwards Lifesciences Corporation has appointed Theodora Mistras as Chief Financial Officer, effective May 29, 2026… May 4, 2026 Edwards Lifesciences Corporation issued a press release on April 23, 2026, announcing its financial results for the… Apr 23, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.